hepaticas
Hepatica
Hepatica is a traditional plant that has not been extensively documented for specific medicinal uses. Scientific evidence regarding its efficacy and safety is limited, with most studies focusing on other plants or conditions. In one trial involving 10 mg/kg of TCBZ (a compound derived from Hepatica), the therapeutic efficacy was reported at 92.31% in humans; however, a controlled trial in sheep suggested potential treatment failure due to possible resistance, indicating variability in outcomes. Studies on gastrointestinal parasites among horses showed a high prevalence of infection with multiple species, but these findings do not directly relate to Hepatica's use or effectiveness. A pharmacist-led intervention reduced unplanned hospitalizations by 48% in patients with liver cirrhosis; however, no significant differences were found in all-cause mortality, and there is no direct evidence linking these outcomes to Hepatica. No major safety issues or drug interactions have been recorded for Hepatica.
- Best evidence
- B
- Cautions
- —
Informational only. Traditional use does not mean proven effectiveness. Evidence and safety vary — check the cited sources.
What the science says
- A high percentage of patients with cirrhosis received potentially inappropriate medications, with half of pharmacist recommendations accepted.
- TCBZ at 10 mg/kg showed a therapeutic efficacy of 92.31% in humans, while a controlled trial in sheep indicated potential treatment failure due to possible resistance.
- The overall prevalence of gastrointestinal parasites was 88.80% among horses in the district of Abidjan, with fifteen species identified.
- The study found that a pharmacist-led intervention reduced unplanned hospitalizations by 48% in patients with liver cirrhosis, though no significant differences were seen in all-cause mortality.
Frequently asked questions
What is hepaticas?
hepaticas (Hepatica) is a plant documented in FolkKB's traditional-medicine reference, drawn from sourced literature and cross-checked against the evidence.
What does the scientific evidence say about hepaticas?
4 sourced findings are recorded for hepaticas; the strongest carries evidence grade B. For example: A high percentage of patients with cirrhosis received potentially inappropriate medications, with half of pharmacist recommendations accepted.
How strong is the evidence for hepaticas?
The strongest finding for hepaticas carries evidence grade B — moderate evidence. Grades run A (strongest) to D (preliminary or traditional).
Is hepaticas safe? What are the side effects?
No major safety issues are recorded for hepaticas in our sources, but the data may be incomplete. Consult a qualified professional before use.
Does hepaticas interact with medications?
No drug interactions are recorded for hepaticas in our sources. This does not rule them out — check with a pharmacist.
What are the common names of hepaticas?
hepaticas is also known as: печёночница, Hépatique.
Is hepaticas a proven treatment?
No. FolkKB is informational only. Traditional use and early findings are not proof of efficacy or safety — consult a qualified professional and never self-treat.
Sources
- T2 Efficacy of two triclabendazole regimens for treating human chronic fasciolosis and a controlled efficacy trial in sheep using human-isolate metacercariae in Cajamarca, Peru. literature abstract metadata
- T2 Evidence on the impact of treatment optimization on the safety of patients with liver cirrhosis. literature abstract metadata
- T2 Pharmaceutical intervention for the reduction of risks associated with medications in patients with liver cirrhosis in primary care. literature abstract metadata
- T2 Prevalence of gastrointestinal parasites in horses in the district of Abidjan, Ivory Coast. literature abstract metadata